ArticleInternational ophthalmology2018
Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis.
Georgios Makragiannis et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it